Evaluating decision-making for appendicitis treatment options
Treatment Individualized Appendicitis Decision-Making (TRIAD) Patient Surveys
This study is trying to see how satisfied people with appendicitis are with their treatment choices, like antibiotics or surgery, and how those choices affect their feelings about the decisions they made.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Washington Academic / other |
| Locations | 17 sites (Baldwin Park, California and 16 other locations) |
| Trial ID | NCT05887414 on ClinicalTrials.gov |
What this trial studies
The TRIAD project aims to assess patient satisfaction and decisional regret regarding treatment options for appendicitis, specifically comparing antibiotics and surgery. Through cross-sectional surveys, patients diagnosed with appendicitis will provide insights into their awareness of treatment options and the decision-making process. The study will utilize the Ottawa Decisional Conflict Score to measure decisional conflict and will follow up with participants 30 days after their initial survey. The findings will inform the development of decision-support tools to enhance patient decision-making aligned with their preferences.
Who should consider this trial
Good fit: Ideal candidates include adults diagnosed with appendicitis who are considering either antibiotics or surgery as treatment options.
Not a fit: Patients who are pregnant, immunocompromised, or have high complication risks will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could empower patients with better information to make informed decisions about their treatment for appendicitis.
How similar studies have performed: Previous studies have shown that decision-support tools can improve patient outcomes, making this approach promising but not entirely novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Any patient the clinical team feels is appropriate for considering either surgery or antibiotics for their initial appendicitis treatment Exclusion Criteria: * Pregnant patients * Immunocompromised patients * Patients with high complication risk of recurrent infections * Evidence of severe phlegmon or walled off abscess or free air on imaging * Septic shock * Diffuse peritonitis * Patients under 18 years old
Where this trial is running
Baldwin Park, California and 16 other locations
- Kaiser Permanente Baldwin Park — Baldwin Park, California, United States (Recruiting)
- Kaiser Permanente Los Angeles — Los Angeles, California, United States (Recruiting)
- Kaiser Permanente Riverside — Riverside, California, United States (Not_yet_recruiting)
- Grady Health System / Morehouse School of Medicine — Atlanta, Georgia, United States (Not_yet_recruiting)
- Northwestern Medicine — Chicago, Illinois, United States (Recruiting)
- University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States (Recruiting)
- Boston Medical Center — Boston, Massachusetts, United States (Recruiting)
- Michigan Medicine- University of Michigan — Ann Arbor, Michigan, United States (Recruiting)
- Columbia University Medical Center — New York, New York, United States (Recruiting)
- Atrium Health — Charlotte, North Carolina, United States (Recruiting)
- Medical University of South Carolina — Charleston, South Carolina, United States (Recruiting)
- Lyndon B Johnson- Harris Health — Houston, Texas, United States (Not_yet_recruiting)
- The University of Texas Health Science Center at Houston — Houston, Texas, United States (Recruiting)
- Texas Tech University — Lubbock, Texas, United States (Not_yet_recruiting)
- Harborview Medical Center — Seattle, Washington, United States (Recruiting)
- Northwest Hospital and Medical Center — Seattle, Washington, United States (Recruiting)
- University of Washington Medical Center — Seattle, Washington, United States (Recruiting)
Study contacts
- Principal investigator: Giana Davidson, MD, MPH — University of Washington
- Study coordinator: Sara DePaoli
- Email: sdepaoli@uw.edu
- Phone: 206-543-8624
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.